Showing 1191-1200 of 1857 results for "".
PBM Restrictions Force Dermatologists to Consider OTC Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pbm-restrictions-force-dermatologists-to-consider-otc-products/23578/The latest generation of OTC products for some common dermatologic diseases often feature innovative formulations and clinical studies to show efficacy.The Importance of Tax Diversification in Your Long-Term Financial Plan
https://practicaldermatology.com/topics/practice-management/the-importance-of-tax-diversification-in-your-long-term-financial-plan/23547/Tips for preparing for potential tax increases now and in the future.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-25/23543/Credentialing: Building Confidence and Trust
https://practicaldermatology.com/topics/practice-management/credentialing-building-confidence-and-trust/23498/Tips for training staff to answer questions and use credentialing throughout the patient journey to earn loyalty.Permanent Life Insurance, Part 2
https://practicaldermatology.com/topics/practice-management/permanent-life-insurance-part-2/23462/Who should use it and how, and who should not utilize this type of insurance.Permanent Life Insurance: What It Is and Why a New Law Has Made It Better
https://practicaldermatology.com/topics/practice-management/permanent-life-insurance-what-it-is-and-why-a-new-law-has-made-it-better/23443/A review of what this insurance offers.Get The Word Out: Branding Plus Online Presence Equals Reputation Building
https://practicaldermatology.com/topics/practice-management/get-the-word-out-branding-plus-online-presence-equals-reputation-building/23441/Your online branding program and associated initiatives can improve your web ranking and your appeal to patients.Cutaneous T-Cell Lymphoma: Mogamulizumab as a Novel Treatment for Refractory Mycosis Fungoides and Sezary Syndrome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/Cutaneous-T-Cell-Lymphoma-Mogamulizumab-as-a-Novel-Treatment-for-Refractory-Mycosis-Fungoides-and-Sezary-Syndrome/23409/An overview of the diagnosis and prognosis of CTCL.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-20/23397/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-19/23381/